8/30/2013

Cardium Therapeutics has filed a new 510(k) clearance application with the FDA for its wound-therapy product called Excellagen. The new submission includes packaging modifications, more specific labeling and research data indicating that the product can boost platelet activation when used in conjunction with platelet-rich plasma therapy.

Related Summaries